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cates that Nath et al. (1) selected a low risk group for 
muitivessel angioplasty. Although this group may be most 
appropriate for multivessel angioplasty soon after myocar- 
dial infarction, one would expect such patients to also have 
an excellent outcome and 9ow mortality with other treat- 
ment-surgical management or possibly medical therapy. 
Because the results of this study were obtained in low risk 
patients, itmay noi be possible to obtain similar esults in a 
higher isk group. 
Of the patients reported on by Nath et al. (9) 21% 
received thrombolytic therapy before angioplasty. This pro- 
portion of patients receiving tbrombo9yt~c herapy for Q 
wave infarction is similar to the experience of others (5,6) 
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is of interest that Natb and colleagues (9) only performed 
primary angioplasty in one patient in whom they dilated the 
infarct vessel as the first of a two stage procedure. 
cations for a~g~o~~as~y in evolving 
be9 that there is an important role 
plasty in these patients with evolving Q wave infarction who 
have contraindications to thrombolytic therapy. Although 
the relative fficacy and safety of primary angioplasty versus 
intravenous thrombolytic therapy has not been carefully 
evaluated with a large ran ized trial, it is likely that 
coronary artery reperfusion omplished by direct angio- 
plasty will result in improved survival in hi 
as has thrombolytic therapy (99). 
<300/o of patients with acute my0 
for thrombolytic therapy, there is a 
patients who may benefit from primary angiophtsty. The 
results of Nath et al. (I) indicate that staged muhivesse9 
angioplasty several days after acute myocardial infarction is
a safe and effective procedure inselected low risk 
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This approach, following primary angioplasty of the infarct 
vessel in patients who are not suitable for intravenous 
thrombolytic therapy, has the potential to provide the ben- 
efits of more complete r perfusion therapy to a Iarger portion 
of patients with acute myocardia! infarction. If primary 
angioplasty is to be provided to a large number of patients, 
many more hospitals and catheterization laboratories will 
have to develop these programs. If this cannot be done, the 
reduction in morbidity and mortality provided by reperfu- 
sion therapy will remain limited to the minority of patients 
with acute myocardial infarction who are currently candi- 
dates for thrombolytic herapy. 
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